Explore

Trendline Trendline
NVE Corporation Reports Revenue Growth and Dividend Payout for FY26

NVE Corporation Reports Revenue Growth and Dividend Payout for FY26

NVE Corporation Reports Revenue Growth and Dividend Payout for FY26
Trendline Trendline
Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss

Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss

Supernus Pharmaceuticals Reports Strong Revenue Growth Despite Earnings Miss
Trendline Trendline
Elanco Animal Health Reports Strong Q1 2026 Results and Raises Full-Year Guidance

Elanco Animal Health Reports Strong Q1 2026 Results and Raises Full-Year Guidance

Elanco Animal Health Reports Strong Q1 2026 Results and Raises Full-Year Guidance
Trendline Trendline
Thomson Reuters Reports Strong Q1 2026 Financial Results with Revenue Growth

Thomson Reuters Reports Strong Q1 2026 Financial Results with Revenue Growth

Thomson Reuters Reports Strong Q1 2026 Financial Results with Revenue Growth
Trendline Trendline
Peloton Reports Profit as Subscription Price Hikes Boost Revenue

Peloton Reports Profit as Subscription Price Hikes Boost Revenue

Peloton Reports Profit as Subscription Price Hikes Boost Revenue
Trendline Trendline
Coeur Mining Reports Q1 Earnings Below Expectations, Revenue Surpasses Estimates

Coeur Mining Reports Q1 Earnings Below Expectations, Revenue Surpasses Estimates

Coeur Mining Reports Q1 Earnings Below Expectations, Revenue Surpasses Estimates
Trendline Trendline
Steve Madden Reports Strong Q1 Earnings, Raises 2026 Revenue Guidance

Steve Madden Reports Strong Q1 Earnings, Raises 2026 Revenue Guidance

Steve Madden Reports Strong Q1 Earnings, Raises 2026 Revenue Guidance
Trendline Trendline
SelectQuote Reports Strong Q3 2026 Financial Results Amid Market Shifts

SelectQuote Reports Strong Q3 2026 Financial Results Amid Market Shifts

SelectQuote Reports Strong Q3 2026 Financial Results Amid Market Shifts
Trendline Trendline
V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance

V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance

V2X Reports Strong First Quarter 2026 Financial Results and Increases Full-Year Guidance
Trendline Trendline
Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance

Palantir Technologies Reports Significant Q1 2026 Revenue Growth, Raises Full-Year Guidance
Trendline Trendline
Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss

Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss

Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss
Trendline Trendline
V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance

V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance

V2X Reports Strong Q1 2026 Financial Results, Increases Full-Year Guidance